ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review
- PMID: 20082857
- DOI: 10.1016/j.cancergencyto.2009.09.018
ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review
Abstract
Entire ABL1 gene deletion without BCR/ABL1 rearrangement is a rare phenomenon, with only four cases previously reported. Here we describe a fifth case of ABL1 deletion without BCR/ABL1 rearrangement in an adolescent patient with precursor B-cell lymphoblastic leukemia (B-ALL) and review the relevant literature. It is not clear how ABL1 deletion affects leukemogenesis; however, it is plausible that ABL1 deletion without BCR/ABL1 rearrangement is a rare but recurrent genetic abnormality in precursor B-ALL patients. Further studies are needed to evaluate the extent of the submicroscopic defects in chromosome 9 including ABL1 gene deletion, as well as treatment response and prognosis in long-term follow-up of such patients.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.J Clin Oncol. 2009 Nov 1;27(31):5202-7. doi: 10.1200/JCO.2008.21.6408. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770381
-
Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.Genes Chromosomes Cancer. 2006 Jun;45(6):575-82. doi: 10.1002/gcc.20320. Genes Chromosomes Cancer. 2006. PMID: 16518848
-
CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.Int J Lab Hematol. 2011 Feb;33(1):92-6. doi: 10.1111/j.1751-553X.2010.01254.x. Int J Lab Hematol. 2011. PMID: 20666852
-
[Bcr-abl translocation: diagnostic methods and clinical value].Ann Biol Clin (Paris). 1998 Jan-Feb;56(1):57-63. Ann Biol Clin (Paris). 1998. PMID: 9754223 Review. French.
-
ABL1 rearrangements in T-cell acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2010 Apr;49(4):299-308. doi: 10.1002/gcc.20743. Genes Chromosomes Cancer. 2010. PMID: 20073070 Review.
Cited by
-
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer.Transl Oncol. 2021 Mar;14(3):101013. doi: 10.1016/j.tranon.2021.101013. Epub 2021 Jan 27. Transl Oncol. 2021. PMID: 33516089 Free PMC article.
-
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias.Blood Cancer J. 2023 Mar 23;13(1):42. doi: 10.1038/s41408-023-00810-0. Blood Cancer J. 2023. PMID: 36959186 Free PMC article.
-
Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL.Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):462-464. doi: 10.1016/j.htct.2022.01.016. Epub 2022 Mar 25. Hematol Transfus Cell Ther. 2024. PMID: 35365438 Free PMC article. No abstract available.
-
Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.Onco Targets Ther. 2020 Jan 24;13:783-790. doi: 10.2147/OTT.S238336. eCollection 2020. Onco Targets Ther. 2020. PMID: 32158229 Free PMC article.
-
A rare case of microgranular acute promyelocytic leukemia associated with ider(17)(q10)t(15;17) in an old-age patient.Korean J Lab Med. 2011 Apr;31(2):86-90. doi: 10.3343/kjlm.2011.31.2.86. Korean J Lab Med. 2011. PMID: 21474981 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous